Hypertrophic Obstructive Cardiomyopathy Clinical Trial
Official title:
Minimally Invasive Transapical Septal Myectomy in the Beating Hearts for the Treatment of Hypertrophic Obstructive Cardiomyopathy: a Multi-Center Study
The primary purpose of this study is to evaluate the feasibility, the safety and the efficacy of the transapical beating-heart septal myectomy for the treatment of hypertrophic obstructive cardiomyopathy. This is a prospective, single-arm, multi-center study.
Surgical septal myectomy remains the gold standard for the treatment of hypertrophic obstructive cardiomyopathy. However, conventional septal myectomy is hindered by the demanding expertise that is needed to sufficient relieve the obstruction of the left ventricle outflow tract while guarantee safety. To increase the visualization and minimize the surgical injury of conventional septal myectomy, the investigators have invented a novel beating-heart myectomy device. Through a mini-thoractomy, septal myectomy could be accomplished via a transapical access in the beating heart using the beating-heart myectomy device. The whole process of resection is monitored, navigated, and evaluated by real-time transesophageal and transthoracic echocardiography. Left ventricle outflow tract gradient and the grade of mitral regurgitation are evaluated each time after resection. Multiple resections are performed to tailor sufficient relief of left ventricle outflow tract obstruction and mitral regurgitation, while preventing iatrogenic injuries. After transapical beating-heart septal myectomy, participants is scheduled to be seen for follow-up visits at discharge (about 7 days post operation) and 3 months. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05073094 -
Esmolol for Myocardial Protection in Hypertrophic Obstructive Cardiomyopathy
|
Phase 4 | |
| Completed |
NCT05850026 -
Mitral Regurgitation in Hypertrophic Obstructive Cardiomyopathy: Fix it in a Simple, Effective and Durable Way!
|
||
| Completed |
NCT04777188 -
Speckle Tracking Echocardiography Analysis of Left Ventricular Myocardium After Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy
|
N/A | |
| Completed |
NCT02054221 -
Surgical Treatment of Hypertrophic Obstructive Cardiomyopathy With Severe Mitral Insufficiency.
|
N/A | |
| Withdrawn |
NCT04905173 -
Comparison of Squat-to-Stand Maneuver With Amyl Nitrite, Valsalva, and Exercise Stress Echocardiography in Inducing Latent Left Ventricular Outflow Obstruction in Hypertrophic Cardiomyopathy
|
N/A | |
| Completed |
NCT04066777 -
The Effect of TASH in Patients With HOCM
|
N/A | |
| Terminated |
NCT02674958 -
Mobilization of Endothelial Progenitor Cells and Aspirin
|
Phase 3 | |
| Not yet recruiting |
NCT04329689 -
Hyp Obst Cardiomyopathy
|
N/A | |
| Not yet recruiting |
NCT05025644 -
Quantitative Assessment of Hypertrophic Obstructive Cardiomyopathy With Intraoperative Three-dimensional Transesophageal Echocardiography Under Provocative Dobutamine Stress Test
|
Phase 4 | |
| Recruiting |
NCT05257772 -
Electromechanically Optimised Right Ventricular Pacing In Hypertrophic Cardiomyopathy (EMORI-HCM)
|
N/A | |
| Recruiting |
NCT04470102 -
Edge-to-edge Mitral Valve Repair in the Surgical Treatment for Hypertrophic Cardiomyopathy
|
N/A | |
| Recruiting |
NCT04355260 -
The Clinical Research of the Safety and Effectiveness Evaluation for Using Echocardiography-guided Liwen RF Radiofrequency Ablation System to Treat Hypertrophic Obstructive Cardiomyopathy
|
N/A | |
| Active, not recruiting |
NCT06003478 -
The Safety and Influencing Factors of Liwen Procedure in The Treatment of Hypertrophic Cardiomyopathy
|
||
| Recruiting |
NCT02492399 -
Comparisonof Extended Myoectomy and Myoectomy by Morrow in Patients With Hypertrophic Obstructive Cardiomyopathy (HOCM)
|
N/A | |
| Completed |
NCT04686487 -
SterEotactic AbLative Radiotherapy in PatiEnts With HypertrophiC ObstrucTive Cardiomyopathy
|
N/A | |
| Completed |
NCT05671367 -
Association Between Microvascular Resistance and Outcomes in Patients With Obstructive Hypertrophic Cardiomyopathy
|
||
| Completed |
NCT05687487 -
Residual or Recurrent Obstruction After Septal Myectomy
|
||
| Enrolling by invitation |
NCT05100420 -
Hypertrophic Cardiomyopathy Registry, Biobank and Imaging Data Repository
|
||
| Not yet recruiting |
NCT04275544 -
Risk Factors of Postoperative Complications in HCM Patients
|
||
| Recruiting |
NCT06167876 -
Safety and Efficacy of Stereotactic Body Radiotherapy in the Treatment of Hypertrophic Obstructive Cardiomyopathy
|
N/A |